80% Taclobanons now fully vaxxed

TACLOBAN CITY- The number of coronavirus disease (COVID-19) in Eastern Visayas continues to decline with the Department of Health (DOH) reporting of just three new cases on Monday(Feb.28), by far the lowest after the region experienced a surge last year.
With the drop of cases in the region since the start of the year, Eastern Visayas has only 113 active COVID-19 cases.
Jelyn Lopez Malibago, regional information officer of the DOH-8, said that the three new cases were from Leyte province with two; and one from Eastern Samar.
Meantime, the 113 active cases are in Leyte with 79 cases; Southern Leyte,17; Samar, 8; Northern Samar, 4; Biliran,3; and two for Eastern Samar.
In Tacloban, the region’s capital city, its COVID-19 cases are also in the declining fashion as it recorded a zero case on Monday for the first time after almost two months.
In fact, its active cases are now at 12, says Dr. Gloria Fabrigas, its city health officer.
The decreasing number of COVID-19 cases of the city was partly attributed to its active campaign on vaccination.
Based on her report, Tacloban City was the first area in the region to achieve 80 percent of its targeted population for vaccination.
Dr. Fabrigas said that as of Monday, the city was able to fully vaccinate 175,162, representing 81.14 percent of the targeted population of more than 215, 800 while around 191, 584 or 88.74 percent of the target have received their first vaccine.
Fabrigas said that she hope with the intensified campaign of the city government, Tacloban will become a zero COVID area which it attained last December.
In Eastern Samar, Governor Ben Evardone has rescinded the requirement on the S-pass for one to enter the province effective Monday.
Based on his order, only a vaccination card will be required for one to be allowed to enter the province.
S-pass is a travel management system developed by the government as a requirement amid the COVID-19 pandemic to one to gain entry to a particular place or office. (with LIZBETH ANN A. ABELLA)